Camden International Financing

Camden is a corporate finance house with a particular specialty in international financing and a special emphasis on the following sectors: biotech, tech, real estate as well as  junior mining and exploration companies.

RECENT PROJECTS: PUBLIC

Canuc resources

Canuc Resources Corporation (TSX-V: CDA) is a junior resource company headquartered in Toronto, Canada focusing on the acquisition and development of quality resource assets.

Inovio

Inovio is developing synthetic DNA vaccines to prevent and treat cancers and infectious disease.

Emerald Health Therapeutics

Is a Health Canada Licensed Producer of medical cannabis.

RECENT PROJECTS: PRIVATE

A private gold mining firm operating in Ghana, sold to a group of private investors.

Aratinga is a french/US company currently reorganizing. Their technology is unique and disruptive.

The CIR Group is the specialist in the rehabilitation of buildings in the city center eligible for the Malraux law, historical monument and land tenure.

Fine Parisian jewelry.

Based in Paris, France, THERAVECTYS is a development-stage biotechnology company with a novel vaccine platform that can be applied to the treatment and prevention of a broad range of infectious diseases, cancers, and other diseases and conditions.

A French startup with a promising technology to address the last mile delivery of goods through an innovative design, Mooveco-Muses wished to gain access to a broader sprectrum of investors in Europe and asked Camden for help.

The project is developed by Rosatom's subsidiary Inter RAO UES. This will be the first Russian nuclear power plant with foreign participation.